Oncology News

The COVID-19 pandemic disrupted treatment for gynecologic cancer patients worldwide and caused disease progression and death, according to a prospective cohort study in American Journal of Obstetrics & Gynecology.

In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more.

Postmenopausal women who consumed at least one serving of sugar-sweetened beverages per day had a 78% greater risk for developing liver cancer compared with those who consumed less than three servings per month, according to recent data.

Black women had an increased risk for not undergoing biopsy within 90 days after abnormal screening mammography results compared with women of other racial and ethnic groups, according to study results published in JAMA Oncology.

Long-term adherence to a healthy plant-based diet was associated with a 14% lower risk for breast cancer among postmenopausal women, according to findings presented at the virtual meeting of the American Society of Nutrition.

Combination therapies appeared associated with better outcomes than monotherapies for treatment of hormone receptor-positive, ERBB2-negative metastatic breast cancer, according to study results published in JAMA Network Open.

Risks for severe maternal morbidity and mortality appeared higher among pregnancies complicated by cancer, according to study results in a research letter published in JAMA Oncology.

Diagnostic mammography performance appeared to vary across racial and ethnic groups, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

Women with recurrent ovarian cancer experience an average of 14 disease or treatment-related symptoms at any given time over the course of their disease.

ATLANTA — Parabens, a class of endocrine-disrupting chemicals widely found in hair and personal care products, promote viability and gene expression of a breast cancer cell line in Black women, according to data presented at ENDO 2022.